Short-Term Outcomes in Patients with Systemic Juvenile Idiopathic Arthritis Treated with either Tocilizumab or Anakinra

Lianne Kearsley-Fleet, Michael W. Beresford, Rebecca Davies, Diederik De Cock, Eileen Baildam, Helen E. Foster, Taunton R. Southwood, Wendy Thomson, Kimme L. Hyrich, Biologics for Children with Rheumatic Diseases Study (BCRD)